Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST‐segment elevation myocardial infarction

Pre‐clinical studies have indicated that mitoprotective drugs may add cardioprotection beyond rapid revascularization, antiplatelet therapy and risk modification. We review the clinical efficacy of mitoprotective drugs that have progressed to clinical testing comprising cyclosporine A, KAI‐9803, MTP...

Descripción completa

Detalles Bibliográficos
Autores principales: Bøtker, Hans Erik, Cabrera‐Fuentes, Hector Alejandro, Ruiz‐Meana, Marisol, Heusch, Gerd, Ovize, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077531/
https://www.ncbi.nlm.nih.gov/pubmed/31967733
http://dx.doi.org/10.1111/jcmm.14953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077531/
https://www.ncbi.nlm.nih.gov/pubmed/31967733
http://dx.doi.org/10.1111/jcmm.14953

Ejemplares similares